US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 13.375
  • -6.735-33.49%
Trading Dec 13 11:51 ET
923.49MMarket Cap-4.08P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicycle Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.251M--
--2024/Q4-- / 5.340M--
--2024/Q32.676M / 7.005M--
--2024/Q29.361M / 6.283M--
--2024/Q119.530M / 6.066M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.251M--
--2024/Q4-- / 5.340M--
--2024/Q32.676M / 7.005M--
--2024/Q29.361M / 6.283M--
--2024/Q119.530M / 6.066M--

Unlock Free Earnings Estimates

Bicycle Therapeutics Earnings Reports

  • Bicycle Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 31 07:25 ET

  • Bicycle Therapeutics | 8-K: Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

    Oct 31 07:10 ET

  • Bicycle Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Bicycle Therapeutics | 8-K: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

    Aug 6 07:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data